The invention belongs to the technical field of valve material preparation, and in particular relates to a long-acting super-hydrophobic anticoagulant biological valve and a preparation method therefor.
Along with the social structure of population in China aging, the number of patients with severe valvular stenosis and regurgitation has increased significantly than before. The overall incidence rate among people over 75 years old is relatively high. Once patients have symptoms and have not received treatment, close to 50% of them may die within 2 to 3 years. Minimally invasive interventional valve surgery is becoming an important treatment accepted by more and more patients because of its small surgical trauma, low risk and good effect. With the development of minimally invasive intervention technology, however, many problems occur. Among them, the implantation of biological valve in interventional therapy may lead to thrombosis, and the detachment of thrombus from the surface of the valve will increase the risk of postoperative stroke; and the thrombosis on the surface of the valve will seriously affect the durability of the valve. Therefore, a biological valve material having an excellent long-acting anticoagulant effect itself is very important for the durability of the valve and the safety of the patient's life.
A super-hydrophobic surface with a bionic structure of lotus leaf has been widely studied due to its high water contact angle (>150°) and low rolling angle, and is mainly used in the fields of self-cleaning, moisture resistance, water-oil separation, corrosion resistance and stain resistance. Once the surface of a common biomaterial comes into contact with blood or body fluid, a large number of proteins or cells will adhere to the surface of the material, which will seriously affect the performance of the material. However, superhydrophilic surfaces and super-hydrophobic surfaces both have a good stain resistance (resistance to non-specific adhesion of proteins, cells and microorganisms). Studies have reported that, compared with superhydrophilic surfaces, super-hydrophobic surfaces have lower platelet adhesion ability, indicating that super-hydrophobic surfaces have better antithrombotic properties. Currently, the super-hydrophobic surfaces are mainly prepared on the surface of metals, polymers and inorganic materials, and few studies are made on the preparation of super-hydrophobic coatings on the surface of biological valve materials. Therefore, the preparation of super-hydrophobic coatings with high water contact angle and low adhesion on the surface of biological valve materials are crucial to resist thrombosis after the valve being implanted in vivo.
In view of the above-mentioned deficiencies in the prior art, the present invention provides a long-acting super-hydrophobic anticoagulant biological valve and the preparation method thereof, which can prepare a layer of super-hydrophobic coating with high water contact angle and a low rolling angle on the surface of the biological valve material without changing the mechanical properties of the valve body, thereby improving the antithrombotic performance of the biological valve after being implanted in the human body.
In order to achieve the above object, the technical solution adopted by the present invention to solve the technical problems is:
A preparation method for a long-acting super-hydrophobic anticoagulant biological valve, includes the following steps:
Further, the treating with glutaraldehyde in step (1) specifically includes immersing the biological valve material in a glutaraldehyde solution for 48 h to 96 h.
Further, in step (2), the oxidant has a concentration of 20 μM to 1 mM, and the reaction is performed at 10° C. to 40° C. for 20 min to 120 min.
Further, the molar mass ratio of the polyphenol compound and the metal ions is 1:0.01 to 1.
Further, the polyphenol compound is at least one of tannic acid, gallic acid, salvianolic acid B, epigallocatechin gallate, epicatechin gallate, epicatechin, epigallocatechin, catechol, pyrogallol, and flavonoid.
Further, the metal ions are at least one of copper ions, silver ions and iron ions.
Further, the acid solution has a pH value ranging from 4 to 6.
Further, the acid solution is acetic acid-acetate buffer, 2-(N-morpholine) ethanesulfonic acid buffer, glycine-hydrochloric acid buffer, phthalic acid-hydrochloric acid buffer, potassium hydrogen phthalate-sodium hydroxide buffer, disodium hydrogen phosphate-citric acid buffer or citric acid-sodium hydroxide-hydrochloric acid buffer.
Further, the oxidant is a water-soluble oxidant, which is, in particular, at least one of hydrogen peroxide, ammonium persulfate, cupric chloride, ferric chloride, concentrated nitric acid, sodium periodate, potassium permanganate and potassium dichromate.
Further, the step (3) specifically includes:
Further, the hydrophobic substance is perfluoropentadecane, perfluorododecanoic acid, 1H, 1H, 2H, 2H— perfluorododecanethiol, perfluorobutylethylene, stearoyl chloride or stearic acid.
Further, the biological valve material is an aortic valve, a pulmonary valve, a venous valve, a mitral valve or a tricuspid valve.
Further, the biological valve material is selected from porcine pericardium or bovine pericardium or the like.
The present invention further provides a long-acting super-hydrophobic anticoagulant biological valve, including a biological valve material, nanoparticles embedded in a surface of the biological valve material and formed by polymerization of a polyphenol compound and metal ions and containing double bond groups, and a hydrophobic coating formed by grafting a hydrophobic substance on surfaces of the nanoparticles.
The long-acting super-hydrophobic anticoagulant biological valve can be prepared by any of the above-mentioned preparation methods.
The technical advantages of the present invention are:
The specific embodiments of the present invention are described below so that those skilled in the art can understand the present invention, but it should be noted that the present invention is not limited to the scope of the specific embodiments. For those skilled in the art, various modifications within the spirit and scope of the present invention defined and determined by the appended claims are obvious, and all inventions using the concept of the present invention fall in the protection scope of the present invention.
A method for preparing a long-acting super-hydrophobic anticoagulant biological valve, includes the following steps:
A method for preparing a long-acting super-hydrophobic anticoagulant biological valve, includes the following steps:
A method for preparing a long-acting super-hydrophobic anticoagulant biological valve, includes the following steps:
A method for preparing a long-acting super-hydrophobic anticoagulant biological valve, includes the following steps:
1. The SEM image of the super-hydrophobic coating of the biological valve material prepared in Example 2 is shown in
As shown in
2. Taking a glutaraldehyde valve as a control group and the biological valve material prepared in Example 2 as the experimental group, an in vitro platelet adhesion experiment was carried out to detect the anticoagulant performance, and the results are shown in
As shown in
Number | Date | Country | Kind |
---|---|---|---|
202011524829.3 | Dec 2020 | CN | national |
The present application is a Continuation Application of PCT Application No. PCT/CN2021/140378, filed on Dec. 22, 2021, which claims the priority of Chinese Application No. 202011524829.3, filed on Dec. 22, 2020, the entire contents of which are hereby incorporated by reference.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/CN2021/140378 | Dec 2021 | US |
Child | 18211274 | US |